10 years have already passed since the heated discussion arose on the drug reclassification and sale of over-the-counter drugs in non-pharmacy venues. As the Korean saying goes, even nature can change in one decade. In that not-so-long but also an epoch of a period in terms of change, many drugs have established safety profiles and await better patient access. In other words, the time has now come for discussions on drug reclassifications, just as we have done in 2012 a decade ago.

Above all, we need to make an opportunity to discuss reclassifications because no system that regularly reclassifies drugs exist in Korea. The Ministry of Food and Drug Safety announced that it would establish a regular syst